Kimia Farma, officially known as PT Kimia Farma Tbk, is a prominent player in Indonesia's pharmaceutical industry, headquartered in Jakarta. Established in 1817, it stands as one of the oldest pharmaceutical companies in the country, with a rich history marked by significant milestones in healthcare innovation and accessibility. The company operates extensively across Indonesia, focusing on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal remedies. Kimia Farma is renowned for its commitment to quality and affordability, making healthcare accessible to a broader population. With a strong market position, Kimia Farma has achieved notable recognition for its extensive network of pharmacies and healthcare services, contributing significantly to Indonesia's healthcare landscape. Its dedication to research and development further solidifies its reputation as a leader in the pharmaceutical sector.
How does Kimia Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kimia Farma's score of 26 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Kimia Farma reported total carbon emissions of approximately 15,595,830 kg CO2e, comprising 20,960 kg CO2e from Scope 1 and about 15,574,870 kg CO2e from Scope 2 emissions. This marks a significant reduction from 2023, where emissions totalled approximately 12,182,960 kg CO2e, with Scope 1 emissions at 255,190 kg CO2e and Scope 2 emissions at about 11,927,780 kg CO2e. Over the past few years, Kimia Farma has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The company operates as a current subsidiary of PT Kimia Farma Tbk, which may influence its climate strategies and reporting practices. The emissions data indicates a focus on improving energy efficiency and reducing reliance on fossil fuels, particularly in their operations. However, there is currently no reported data on Scope 3 emissions, which encompass indirect emissions in the value chain. Overall, Kimia Farma's emissions data reflects ongoing efforts to address climate change, aligning with broader industry trends towards sustainability and carbon neutrality.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 193,144,650 | 0,000,000,000 | 000,000 | 000,000 | 00,000 |
| Scope 2 | - | - | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kimia Farma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

